

Blogs
May 31, 2025
Introducing Nexomic: NexGen Precision
Introducing Nexomic: NexGen Precision
At Nexomic, we believe medicine should feel personal. No two patients are the same, so why should their treatments be? Too often, though, care still relies on trial and error. We started Nexomic to change that to bring together the power of biology and AI so that every decision in healthcare is better informed, more confident, and truly individualized.
The cost of trial-and-error care
Think about the frustration of being prescribed a medication that does not work the first time. Nearly half of patients face this reality, often cycling through multiple treatments before finding the right one. Behind those statistics are real people: families waiting for answers, patients losing precious time, and clinicians trying to make the best decisions without the right tools.
Almost everyone carries genetic differences that affect how they respond to medicine. Precision, not averages, must guide the future of treatment.
Our mission
Our mission is clear: advancing precision medicine through breakthrough discoveries and transformative solutions.
We are committed to turning complex biology into practical insights that empower clinicians, researchers, and biopharma to make faster, more confident decisions.
How we work
We combine multi-omics with AI in a way that is algorithm-first, molecularly informed, and privacy by design. Our focus is not just on building models but on creating secure, trustworthy tools that fit into real workflows and deliver insights where they matter most.
Why today, not tomorrow
The timing has never been better. Advances in data, computing, and AI mean that what once seemed out of reach can now become reality. Precision medicine is projected to grow into a $500 billion market by 2034, but more importantly, it has the potential to become the standard of care. The opportunity is not just to participate in that shift, but to help lead it.
Looking ahead
Nexomic is just beginning, but our vision is bold. We want to help create a world where patients do not have to endure trial and error, where clinicians have the insights they need at their fingertips, and where discoveries move quickly into real decisions.
We are grateful to the community of researchers, clinicians, and partners who share this vision. Together, we can advance precision medicine through breakthrough discoveries and transformative solutions and make precision the default, not the exception.
At Nexomic, we believe medicine should feel personal. No two patients are the same, so why should their treatments be? Too often, though, care still relies on trial and error. We started Nexomic to change that to bring together the power of biology and AI so that every decision in healthcare is better informed, more confident, and truly individualized.
The cost of trial-and-error care
Think about the frustration of being prescribed a medication that does not work the first time. Nearly half of patients face this reality, often cycling through multiple treatments before finding the right one. Behind those statistics are real people: families waiting for answers, patients losing precious time, and clinicians trying to make the best decisions without the right tools.
Almost everyone carries genetic differences that affect how they respond to medicine. Precision, not averages, must guide the future of treatment.
Our mission
Our mission is clear: advancing precision medicine through breakthrough discoveries and transformative solutions.
We are committed to turning complex biology into practical insights that empower clinicians, researchers, and biopharma to make faster, more confident decisions.
How we work
We combine multi-omics with AI in a way that is algorithm-first, molecularly informed, and privacy by design. Our focus is not just on building models but on creating secure, trustworthy tools that fit into real workflows and deliver insights where they matter most.
Why today, not tomorrow
The timing has never been better. Advances in data, computing, and AI mean that what once seemed out of reach can now become reality. Precision medicine is projected to grow into a $500 billion market by 2034, but more importantly, it has the potential to become the standard of care. The opportunity is not just to participate in that shift, but to help lead it.
Looking ahead
Nexomic is just beginning, but our vision is bold. We want to help create a world where patients do not have to endure trial and error, where clinicians have the insights they need at their fingertips, and where discoveries move quickly into real decisions.
We are grateful to the community of researchers, clinicians, and partners who share this vision. Together, we can advance precision medicine through breakthrough discoveries and transformative solutions and make precision the default, not the exception.
At Nexomic, we believe medicine should feel personal. No two patients are the same, so why should their treatments be? Too often, though, care still relies on trial and error. We started Nexomic to change that to bring together the power of biology and AI so that every decision in healthcare is better informed, more confident, and truly individualized.
The cost of trial-and-error care
Think about the frustration of being prescribed a medication that does not work the first time. Nearly half of patients face this reality, often cycling through multiple treatments before finding the right one. Behind those statistics are real people: families waiting for answers, patients losing precious time, and clinicians trying to make the best decisions without the right tools.
Almost everyone carries genetic differences that affect how they respond to medicine. Precision, not averages, must guide the future of treatment.
Our mission
Our mission is clear: advancing precision medicine through breakthrough discoveries and transformative solutions.
We are committed to turning complex biology into practical insights that empower clinicians, researchers, and biopharma to make faster, more confident decisions.
How we work
We combine multi-omics with AI in a way that is algorithm-first, molecularly informed, and privacy by design. Our focus is not just on building models but on creating secure, trustworthy tools that fit into real workflows and deliver insights where they matter most.
Why today, not tomorrow
The timing has never been better. Advances in data, computing, and AI mean that what once seemed out of reach can now become reality. Precision medicine is projected to grow into a $500 billion market by 2034, but more importantly, it has the potential to become the standard of care. The opportunity is not just to participate in that shift, but to help lead it.
Looking ahead
Nexomic is just beginning, but our vision is bold. We want to help create a world where patients do not have to endure trial and error, where clinicians have the insights they need at their fingertips, and where discoveries move quickly into real decisions.
We are grateful to the community of researchers, clinicians, and partners who share this vision. Together, we can advance precision medicine through breakthrough discoveries and transformative solutions and make precision the default, not the exception.
Recent Articles

News
08 march 2024

News
08 march 2024

News
08 march 2024

News
08 march 2024

News
08 march 2024

News
08 march 2024

News
08 march 2024
Nexomic in Action
Explore the Power of NexGen Precision
Request access and we’ll tailor a brief
walkthrough to your use case
Nexomic in Action
Explore the Power of NexGen Precision
Request access and we’ll tailor a brief
walkthrough to your use case
Dublin, Ireland
Solutions